Fineline Cube

Follow:
14433 Articles
DeepSeek Enhances Biopharma IND and NDA Processes with AI
CompanyDigital

DeepSeek Enhances Biopharma IND and NDA Processes with AI

Enhertu Approved by FDA for HR-Positive, HER2-Low Breast Cancer
CompanyDrug

Enhertu Approved by FDA for HR-Positive, HER2-Low Breast Cancer

Suzhou Vigonvita Life Sciences Files for HKEX IPO
Company

Vigonvita Life Sciences Targets HKEX IPO with Integrated Biopharma Model

CompanyDeals

CStone Pharmaceuticals Partners with SteinCares for Sugemalimab Commercialization in Latin America

MicroPort's Fireliums Receives NMPA Approval for Coronary Bifurcation Stenosis Treatment
CompanyMedical Device

MicroPort’s Fireliums Receives NMPA Approval for Coronary Bifurcation Stenosis Treatment

MicroPort's TomaHawk Intravascular Shock Wave Therapy Device Approved by NMPA
CompanyMedical Device

MicroPort’s TomaHawk Intravascular Shock Wave Therapy Device Approved by NMPA

FDA Clears sBLA for Eisai and Biogen's Leqembi Maintenance Dosing
CompanyDrug

FDA Clears sBLA for Eisai and Biogen’s Leqembi Maintenance Dosing

Jiangsu Yuyue Partners with Inogen for International Distribution and R&D
CompanyDeals

Jiangsu Yuyue Partners with Inogen for International Distribution and R&D

Guangzhou Innogen's Efsubaglutide Alfa Approved by NMPA for Type 2 Diabetes
CompanyDrug

Guangzhou Innogen’s Efsubaglutide Alfa Approved by NMPA for Type 2 Diabetes

MSD and Eisai's Keytruda/Lenvima Combo Shows Promise in Gastroesophageal Cancer Study
CompanyDrug

MSD and Eisai’s Keytruda/Lenvima Combo Shows Promise in Gastroesophageal Cancer Study

NHSA Targets Low-Volume Drugs in National Reimbursement List
Policy / Regulatory

NHSA Targets Low-Volume Drugs in National Reimbursement List

Novo Nordisk's Amycretin Shows Promising Weight Loss Results in Phase Ib/IIa Study
CompanyDrug

Novo Nordisk’s Amycretin Shows Promising Weight Loss Results in Phase Ib/IIa Study